Cleopatra-PD: Clinical efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease

被引：0
|
作者：
Poewe, W. H. [1 ]
Rascol, O. [2 ]
Quinn, N. [3 ]
Tolosa, E. [4 ]
Oertel, W. H. [5 ]
Martignoni, E. [6 ]
Rupp, M. [7 ]
Boroojerdi, B. [7 ]
机构：
[1] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria
[2] Ctr Hosp Univ, Serv Pharmacol Clin, Toulouse, France
[3] UCL, Inst Neurol, London, England
[4] Hosp Clin Univ, Serv Neurol, Barcelona, Spain
[5] Univ Marburg, Dept Neurol, Marburg, Germany
[6] Univ Piemonte Orientale, Novara, Italy
[7] Schwarz Pharma, Monheim, Germany
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2007年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：11 / 11
页数：1
相关论文
共 50 条
  • [1] Clinical efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease (CLEOPATRA-PD)
    Poewe, Werner
    Rascol, Olivier
    Quinn, Niall
    Tolosa, Eduardo
    Oertel, Wolfgang
    Rupp, Markus
    Giladi, Nir
    Boroojerdi, Babak
    NEUROLOGY, 2007, 68 (12) : A260 - A260
  • [2] Results of rotigotine transdermal patch in advanced Parkinson's patients with motor fluctuations and in combination with levodopa: Results of the CLEOPATRA-PD trial
    Poewe, W.
    Oertel, W. H.
    Martignoni, E.
    Tolosa, E.
    Quinn, N. P.
    Boroojerdi, B.
    Rupp, M.
    MOVEMENT DISORDERS, 2007, 22 : S253 - S253
  • [3] Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson’s disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
    Peter A. LeWitt
    Babak Boroojerdi
    Erwin Surmann
    Werner Poewe
    Journal of Neural Transmission, 2013, 120 : 1069 - 1081
  • [4] Rotigotine transdermal system for long-term treatment of patients with advanced Parkinson's disease: results of two open-label extension studies, CLEOPATRA-PD and PREFER
    LeWitt, Peter A.
    Boroojerdi, Babak
    Surmann, Erwin
    Poewe, Werner
    JOURNAL OF NEURAL TRANSMISSION, 2013, 120 (07) : 1069 - 1081
  • [5] Changes in early morning motor status following adjunctive treatment of advanced Parkinson's disease with rotigotine transdermal system in two large, placebo-controlled trials (PREFER and CLEOPATRA-PD)
    Pahwa, R.
    Poewe, W.
    Lyons, K.
    Boroojerdi, B.
    MOVEMENT DISORDERS, 2009, 24 : S280 - S280
  • [6] Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial
    Poewe, Werner H.
    Rascol, Olivier
    Quinn, Niall
    Tolosa, Eduardo
    Oertel, Wolfgang H.
    Martignoni, Emilia
    Rupp, Markus
    Boroojerdi, Babak
    LANCET NEUROLOGY, 2007, 6 (06): : 513 - 520
  • [7] Long-term safety and efficacy of transdermal rotigotine in advanced Parkinson's disease
    Poewe, W. H.
    Rascol, O.
    Quinn, N.
    Tolosa, E.
    Oertel, W. H.
    Giladi, N.
    Boroojerdi, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 128 - 128
  • [8] Clinical pharmacokinetics of pramipexole, ropinirole and rotigotine in patients with Parkinson's disease
    Contin, Manuela
    Lopane, Giovanna
    Mohamed, Susan
    Calandra-Buonaura, Giovanna
    Capellari, Sabina
    De Massis, Patrizia
    Nassetti, Stefania
    Perrone, Alessandro
    Riva, Roberto
    Sambati, Luisa
    Scaglione, Cesa
    Cortelli, Pietro
    PARKINSONISM & RELATED DISORDERS, 2019, 61 : 111 - 117
  • [9] Clinical experience with transdermal patch of rotigotine in Parkinson's disease
    Balaguer Martinez, Ernest
    Callen Soto, Antonio
    Soler Singla, Lluis
    NEUROLOGY, 2008, 70 (11) : A389 - A389
  • [10] Clinical studies with transdermal rotigotine in early Parkinson's disease
    Poewe, W
    Leussi, F
    NEUROLOGY, 2005, 65 (02) : S11 - S14
12345